Sign in
4

Changes in Ownership

Monte Rosa Therapeutics, Inc. Filed Acc 0001193125-26-085677

Principal Accounting Officer sold 25,700 shares at an average $18.09 ($464,886)

  • Principal Accounting Officer acquired 25,700 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Dunn Edmund Principal Accounting Officer 2026-02-27 Option exercise +25,164 $13.41 $337,449 47,857 D: show line 1 in the form
Dunn Edmund Principal Accounting Officer 2026-02-27 Sale −25,164 $18.10 $455,506 22,693 D: show line 2 in the form
Dunn Edmund Principal Accounting Officer 2026-03-02 Option exercise +536 $13.41 $7,188 23,229 D: show line 3 in the form
Dunn Edmund Principal Accounting Officer 2026-03-02 Sale −536 $17.50 $9,380 22,693 D: show line 4 in the form
Open-market sales · 25,700 sh · avg $18.09 · $464,886

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Dunn Edmund Principal Accounting Officer 2026-02-27 Option exercise · Stock Option (Right to Buy) −25,164 536 D: show line 5 in the form
Dunn Edmund Principal Accounting Officer 2026-03-02 Option exercise · Stock Option (Right to Buy) −536 0 D: show line 6 in the form
Loading xslF345X05/ownership.xml…